Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 21
Filtrer
1.
Cytometry A ; 105(5): 382-387, 2024 05.
Article de Anglais | MEDLINE | ID: mdl-38410875

RÉSUMÉ

Finding novel methodologies that enhance the precision, agility, and standardization of drug discovery is crucial for studying leishmaniasis. The slide count is the technique most used to assess the leishmanicidal effect of a given drug in vitro. Despite being consolidated in the scientific environment, it presents several difficulties in its execution, assessment, and results. In addition to being laborious, this technique takes time, both for the preparation of the material for analysis and for the counting itself. Our research group suggests a fresh approach to address this requirement, which involves utilizing nuclear labeling with propidium iodide and flow cytometry to determine the quantity of Leishmania sp. parasites present in macrophages in vitro. Our results show that the fluorescence of infected samples increases as the infection rate increases. Using Pearson's Correlation analysis, it was possible to establish a correlation coefficient (Pearson r = 0.9473) that was strongly positive, linear, and directly proportional to the fluorescence and infection rate variables. Thus, it is possible to infer a mathematical equation through linear regression to estimate the number of parasites in each sample using the Relative Fluorescence Units (RFU) values. This new methodology opens space for the possibility of using this methodological resource in the in vitro quantification of Leishmania in macrophages.


Sujet(s)
Cytométrie en flux , Leishmania , Macrophages , Charge parasitaire , Cytométrie en flux/méthodes , Macrophages/parasitologie , Animaux , Souris , Charge parasitaire/méthodes , Leishmaniose/parasitologie , Propidium , Souris de lignée BALB C
2.
Parasitology ; : 1-14, 2022 Feb 09.
Article de Anglais | MEDLINE | ID: mdl-35346411

RÉSUMÉ

From a systematic review framework, we assessed the preclinical evidence on the effectiveness of drug combinations for visceral leishmaniasis (VL) treatment. Research protocol was based on the PRISMA guideline. Research records were identified from Medline, Scopus and Web of Science. Animal models, infection and treatment protocols, parasitological and immunological outcomes were analysed. The SYRCLE's (SYstematic Review Center for Laboratory Animal Experimentation) toll was used to evaluate the risk of bias in all studies reviewed. Fourteen papers using mice, hamster and dogs were identified. Leishmania donovani was frequently used to induce VL, which was treated with 23 drugs in 40 different combinations. Most combinations allowed to reduce the effective dose, cost and time of treatment, in addition to improving the parasitological control of Leishmania spp. The benefits achieved from drug combinations were associated with an increased drug's half-life, direct parasitic toxicity and improved immune defences in infected hosts. Selection, performance and detection bias were the main limitations identified. Current evidence indicates that combination chemotherapy, especially those based on classical drugs (miltefosine, amphotericin B antimony-based compounds) and new drugs (CAL-101, PAM3Cys, tufisin and DB766), develops additive or synergistic interactions, which trigger trypanocidal and immunomodulatory effects associated with reduced parasite load, organ damage and better cure rates in VL.

3.
Front Nutr ; 9: 825629, 2022.
Article de Anglais | MEDLINE | ID: mdl-35223956

RÉSUMÉ

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been considered a public health emergency, extensively investigated by researchers. Accordingly, the respiratory tract has been the main research focus, with some other studies outlining the effects on the neurological, cardiovascular, and renal systems. However, concerning SARS-CoV-2 outcomes on skeletal muscle, scientific evidence is still not sufficiently strong to trace, treat and prevent possible muscle impairment due to the COVID-19. Simultaneously, there has been a considerable amount of studies reporting skeletal muscle damage in the context of COVID-19. Among the detrimental musculoskeletal conditions associated with the viral infection, the most commonly described are sarcopenia, cachexia, myalgia, myositis, rhabdomyolysis, atrophy, peripheral neuropathy, and Guillain-Barré Syndrome. Of note, the risk of developing sarcopenia during or after COVID-19 is relatively high, which poses special importance to the condition amid the SARS-CoV-2 infection. The yet uncovered mechanisms by which musculoskeletal injury takes place in COVID-19 and the lack of published methods tailored to study the correlation between COVID-19 and skeletal muscle hinder the ability of healthcare professionals to provide SARS-CoV-2 infected patients with an adequate treatment plan. The present review aims to minimize this burden by both thoroughly exploring the interaction between COVID-19 and the musculoskeletal system and examining the cutting-edge 3D cell culture techniques capable of revolutionizing the study of muscle dynamics.

4.
Int J Mol Sci ; 20(21)2019 Oct 25.
Article de Anglais | MEDLINE | ID: mdl-31717698

RÉSUMÉ

Platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) are orthobiologic therapies considered as an alternative to the current therapies for muscle, bone and cartilage. Different formulations of biomaterials have been used as carriers for PRP and BMAC in order to increase regenerative processes. The most common biomaterials utilized in conjunction with PRP and BMAC clinical trials are organic scaffolds and natural or synthetic polymers. This review will cover the combinatorial strategies of biomaterial carriers with PRP and BMAC for musculoskeletal conditions (MsCs) repair and regeneration in clinical trials. The main objective is to review the therapeutic use of PRP and BMAC as a treatment option for muscle, bone and cartilage injuries.


Sujet(s)
Matériaux biocompatibles/pharmacologie , Médecine régénérative/méthodes , Cellules de la moelle osseuse/physiologie , Essais cliniques comme sujet , Humains , Plasma riche en plaquettes/physiologie
5.
J Control Release ; 237: 42-9, 2016 09 10.
Article de Anglais | MEDLINE | ID: mdl-27374631

RÉSUMÉ

Hydrogels are an especially appealing class of biomaterials for gene delivery vehicles as they can be introduced into the body with minimally invasive procedures and are often applied in tissue engineering and regenerative medicine strategies. In this study, we show for the first time the use of an injectable alginate hydrogel for controlled delivery of lentivectors in the skeletal muscle of murine hindlimb. We propose to alter the release rates of lentivectors through manipulation of the molecular weight distribution of alginate hydrogels. The release of lentivector was tested using two different ratios of low and high molecular weight (MW) alginate polymers (75/25 and 25/75 low/high MW). The interdependency of lentivector release rate and alginate degradation rate was assessed in vitro. Lentivector-loaded hydrogels maintained transduction potential for up to one week in vitro as demonstrated by the continual transduction of HEK-293T cells. Injection of lentivector-loaded hydrogel in vivo led to a sustained level of transgene expression for more than two months while minimizing the copies of lentivirus genome inserted into the genome of murine skeletal muscle cells. This strategy of spatiotemporal control of lentivector delivery from alginate hydrogels may provide a versatile tool to combine gene therapy and biomaterials for applications in regenerative medicine.


Sujet(s)
Alginates/composition chimique , Techniques de transfert de gènes , Vecteurs génétiques/administration et posologie , 33783/composition chimique , Lentivirus/génétique , Muscles squelettiques/métabolisme , Transduction génétique/méthodes , Alginates/administration et posologie , Animaux , Matériaux biocompatibles/administration et posologie , Matériaux biocompatibles/composition chimique , Femelle , Vecteurs génétiques/génétique , Acide glucuronique/administration et posologie , Acide glucuronique/composition chimique , Cellules HEK293 , Acides hexuroniques/administration et posologie , Acides hexuroniques/composition chimique , Humains , 33783/administration et posologie , Injections , Souris , Souris de lignée BALB C , Ingénierie tissulaire , Transgènes
6.
FASEB J ; 30(1): 477-86, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-26443826

RÉSUMÉ

Cell-based approaches for bone formation require instructional cues from the surrounding environment. As an alternative to pharmacological strategies or transplanting single cell populations, one approach is to coimplant populations that can establish a new vasculature and differentiate to bone-forming osteoblasts. Mesenchymal stem/stromal cells (MSCs) possess osteogenic potential and produce numerous angiogenic growth factors. Endothelial colony-forming cells (ECFCs) are a subpopulation of endothelial progenitor cells capable of vasculogenesis in vivo and may provide endogenous cues to support MSC function. We investigated the contribution of the carrier biophysical properties to instruct entrapped human MSCs and ECFCs to simultaneously promote their osteogenic and proangiogenic potential. Compared with gels containing MSCs alone, fibrin gels engineered with increased compressive stiffness simultaneously increased the osteogenic and proangiogenic potential of entrapped cocultured cells. ECFCs produced bone morphogenetic protein-2 (BMP-2), a potent osteoinductive molecule, and increases in BMP-2 secretion correlated with gel stiffness. Coculture of MSCs with ECFCs transduced to knockdown BMP-2 production abrogated the osteogenic response to levels observed with MSCs alone. These results demonstrate that physical properties of engineered hydrogels modulate the function of cocultured cells in the absence of inductive cues, thus increasing the translational potential of coimplantation to speed bone formation and repair.


Sujet(s)
Hydrogels/pharmacologie , Cellules souches mésenchymateuses/cytologie , Ostéoblastes/cytologie , Protéine morphogénétique osseuse de type 2/génétique , Protéine morphogénétique osseuse de type 2/métabolisme , Cellules cultivées , Milieux de culture conditionnés/pharmacologie , Progéniteurs endothéliaux/métabolisme , Fibrine/pharmacologie , Humains , Hydrogels/composition chimique , Cellules souches mésenchymateuses/effets des médicaments et des substances chimiques , Ostéoblastes/effets des médicaments et des substances chimiques
7.
Antimicrob Agents Chemother ; 59(10): 5999-6006, 2015 Oct.
Article de Anglais | MEDLINE | ID: mdl-26169419

RÉSUMÉ

Although suramin (Sur) is suggested as a potential drug candidate in the management of Chagas disease, this issue has not been objectively tested. In this study, we examined the applicability of concomitant treatment with benznidazole (Bz) and suramin in mice infected with a virulent strain of Trypanosoma cruzi. Eighty 12-week-old male C57BL/6 mice were equally randomized in eight groups: (i) noninfected mice (negative control) and mice infected with T. cruzi Y strain receiving (ii) no treatment (positive control), (iii) Bz, 100 mg/kg of body weight per day, (iv) Sur, 20 mg/kg/day, and (v to viii) Sur, 20 mg/kg/day, combined with Bz, 100, 50, 25, or 5 mg/kg/day. Bz was administered by gavage, and Sur was administered intraperitoneally. Sur dramatically increased the parasitemia, cardiac content of parasite DNA, inflammation, oxidative tissue damage, and mortality. In response to high parasitic load in cardiac tissue, Sur stimulated the immune system in a manner typical of the acute phase of Chagas disease, increasing tissue levels of gamma interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) and inducing a preferential IgG2a anti-T. cruzi serum pattern. When Sur and Bz were combined, the infection severity was attenuated, showing a dose-dependent Bz response. Sur therapy had a more harmful effect on the host than on the parasite and reduced the efficacy of Bz against T. cruzi infection. Considering that Sur drastically reinforced the infection evolution, potentiating the inflammatory process and the severity of cardiac lesions, the in vivo findings contradicted the in vitro anti-T. cruzi potential described for this drug.


Sujet(s)
Anticorps antiprotozoaires/biosynthèse , Maladie de Chagas/traitement médicamenteux , Nitroimidazoles/pharmacologie , Suramine/effets indésirables , Trypanocides/pharmacologie , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Administration par voie orale , Animaux , Maladie de Chagas/immunologie , Maladie de Chagas/mortalité , Maladie de Chagas/parasitologie , Calendrier d'administration des médicaments , Association de médicaments , Immunoglobuline G/biosynthèse , Injections péritoneales , Interféron gamma/biosynthèse , Mâle , Souris , Souris de lignée C57BL , Nitroimidazoles/antagonistes et inhibiteurs , Charge parasitaire , Analyse de survie , Trypanosoma cruzi/croissance et développement , Trypanosoma cruzi/pathogénicité , Facteur de nécrose tumorale alpha/biosynthèse
8.
IEEE Trans Image Process ; 22(3): 1005-17, 2013 Mar.
Article de Anglais | MEDLINE | ID: mdl-23144033

RÉSUMÉ

Multiscale transforms are among the most popular techniques in the field of pixel-level image fusion. However, the fusion performance of these methods often deteriorates for images derived from different sensor modalities. In this paper, we demonstrate that for such images, results can be improved using a novel undecimated wavelet transform (UWT)-based fusion scheme, which splits the image decomposition process into two successive filtering operations using spectral factorization of the analysis filters. The actual fusion takes place after convolution with the first filter pair. Its significantly smaller support size leads to the minimization of the unwanted spreading of coefficient values around overlapping image singularities. This usually complicates the feature selection process and may lead to the introduction of reconstruction errors in the fused image. Moreover, we will show that the nonsubsampled nature of the UWT allows the design of nonorthogonal filter banks, which are more robust to artifacts introduced during fusion, additionally improving the obtained results. The combination of these techniques leads to a fusion framework, which provides clear advantages over traditional multiscale fusion approaches, independent of the underlying fusion rule, and reduces unwanted side effects such as ringing artifacts in the fused reconstruction.


Sujet(s)
Algorithmes , Amélioration d'image/méthodes , Interprétation d'images assistée par ordinateur/méthodes , Reconnaissance automatique des formes/méthodes , Technique de soustraction , Analyse en ondelettes , Intelligence artificielle , Reproductibilité des résultats , Sensibilité et spécificité , Traitement du signal assisté par ordinateur
9.
IEEE Trans Image Process ; 21(12): 4758-69, 2012 Dec.
Article de Anglais | MEDLINE | ID: mdl-22997263

RÉSUMÉ

Infrared focal-plane array (IRFPA) detectors suffer from fixed-pattern noise (FPN) that degrades image quality, which is also known as spatial nonuniformity. FPN is still a serious problem, despite recent advances in IRFPA technology. This paper proposes new scene-based correction algorithms for continuous compensation of bias and gain nonuniformity in FPA sensors. The proposed schemes use recursive least-square and affine projection techniques that jointly compensate for both the bias and gain of each image pixel, presenting rapid convergence and robustness to noise. The synthetic and real IRFPA videos experimentally show that the proposed solutions are competitive with the state-of-the-art in FPN reduction, by presenting recovered images with higher fidelity.


Sujet(s)
Algorithmes , Traitement d'image par ordinateur/méthodes , Rayons infrarouges , Enregistrement sur magnétoscope/méthodes , Humains
10.
Eur J Immunol ; 42(5): 1203-15, 2012 May.
Article de Anglais | MEDLINE | ID: mdl-22311598

RÉSUMÉ

Dendritic cells (DCs) play an essential role in the modulation of immune responses and several studies have evaluated the interactions between Leishmania parasites and DCs. While extracellular ATP exhibits proinflammatory properties, adenosine is an important anti-inflammatory mediator. Here we investigated the effects of Leishmania infection on DC responses and the participation of purinergic signalling in this process. Bone marrow-derived dendritic cells (BMDCs) from C57BL/6J mice infected with Leishmania amazonensis, Leishmania braziliensis or Leishmania major metacyclic promastigotes showed decreased major histocompatibility complex (MHC) class II and CD86 expression and increased ectonucleotidase expression as compared with uninfected cells. In addition, L. amazonensis-infected DCs, which had lower CD40 expression, exhibited a decreased ability to induce T-cell proliferation. The presence of MRS1754, a highly selective A(2B) adenosine receptor antagonist at the time of infection increased MHC class II, CD86 and CD40 expression in L. amazonensis-infected DCs and restored the ability of the infected DCs to induce T-cell proliferation. Similar results were obtained through the inhibition of extracellular ATP hydrolysis using suramin. In conclusion, we propose that A(2B) receptor activation may be used by L. amazonensis to inhibit DC function and evade the immune response.


Sujet(s)
Antigènes CD40/immunologie , Cellules dendritiques/immunologie , Leishmania/immunologie , Leishmaniose/immunologie , Récepteur A2B à l'adénosine/immunologie , Acétamides/pharmacologie , Antagonistes des récepteurs A2 à l'adénosine/pharmacologie , Animaux , Antigène CD86/biosynthèse , Antigène CD86/immunologie , Cellules de la moelle osseuse/immunologie , Antigènes CD40/biosynthèse , Cellules cultivées , Antigènes d'histocompatibilité de classe II/immunologie , Activation des lymphocytes/immunologie , Souris , Souris de lignée C57BL , Nucleotidases/biosynthèse , Purines/pharmacologie , Suramine/pharmacologie , Lymphocytes T/immunologie , Trypanocides/pharmacologie
11.
IEEE Trans Image Process ; 20(1): 64-75, 2011 Jan.
Article de Anglais | MEDLINE | ID: mdl-21172744

RÉSUMÉ

In this paper, we address the problem of no-reference quality assessment for digital pictures corrupted with blur. We start with the generation of a large real image database containing pictures taken by human users in a variety of situations, and the conduction of subjective tests to generate the ground truth associated to those images. Based upon this ground truth, we select a number of high quality pictures and artificially degrade them with different intensities of simulated blur (gaussian and linear motion), totalling 6000 simulated blur images. We extensively evaluate the performance of state-of-the-art strategies for no-reference blur quantification in different blurring scenarios, and propose a paradigm for blur evaluation in which an effective method is pursued by combining several metrics and low-level image features. We test this paradigm by designing a no-reference quality assessment algorithm for blurred images which combines different metrics in a classifier based upon a neural network structure. Experimental results show that this leads to an improved performance that better reflects the images' ground truth. Finally, based upon the real image database, we show that the proposed method also outperforms other algorithms and metrics in realistic blur scenarios.

12.
Mem Inst Oswaldo Cruz ; 105(6): 818-22, 2010 Sep.
Article de Anglais | MEDLINE | ID: mdl-20944999

RÉSUMÉ

This study evaluated two vaccine candidates for their effectiveness in protecting BALB/c mice against Leishmania chagasi infection. These immunogenic preparations were composed of Leishmania amazonensis or Leishmania braziliensis antigenic extracts in association with saponin adjuvant. Mice were given three subcutaneous doses of one of these vaccine candidates weekly for three weeks and four weeks later challenged with promastigotes of L. chagasi by intravenous injection. We observed that both vaccine candidates induced a significant reduction in the parasite load of the liver, while the L. amazonensis antigenic extract also stimulated a reduction in spleen parasite load. This protection was associated with a suppression of both interleukin (IL)-10 and IL-4 cytokines by spleen cells in response to L. chagasi antigen. No change was detected in the production of IFN-γ. Our data show that these immunogenic preparations reduce the type 2 immune response leading to the control of parasite replication.


Sujet(s)
Antigènes de protozoaire/immunologie , Interleukine-10/biosynthèse , Interleukine-4/biosynthèse , Vaccins antileishmaniose/immunologie , Leishmaniose cutanée/immunologie , Animaux , Antigènes de protozoaire/administration et posologie , Femelle , Interleukine-10/immunologie , Interleukine-4/immunologie , Leishmania brasiliensis/immunologie , Leishmania infantum/immunologie , Leishmania mexicana/immunologie , Leishmaniose cutanée/parasitologie , Leishmaniose cutanée/prévention et contrôle , Foie/parasitologie , Souris , Souris de lignée BALB C , Saponines/administration et posologie , Saponines/immunologie , Rate/parasitologie
13.
Mem. Inst. Oswaldo Cruz ; 105(6): 818-822, Sept. 2010. ilus
Article de Anglais | LILACS | ID: lil-560669

RÉSUMÉ

This study evaluated two vaccine candidates for their effectiveness in protecting BALB/c mice against Leishmania chagasiinfection. These immunogenic preparations were composed of Leishmania amazonensisor Leishmania braziliensisantigenic extracts in association with saponin adjuvant. Mice were given three subcutaneous doses of one of these vaccine candidates weekly for three weeks and four weeks later challenged with promastigotes of L. chagasiby intravenous injection. We observed that both vaccine candidates induced a significant reduction in the parasite load of the liver, while the L. amazonensisantigenic extract also stimulated a reduction in spleen parasite load. This protection was associated with a suppression of both interleukin (IL)-10 and IL-4 cytokines by spleen cells in response to L. chagasiantigen. No change was detected in the production of IFN-γ. Our data show that these immunogenic preparations reduce the type 2 immune response leading to the control of parasite replication.


Sujet(s)
Animaux , Femelle , Souris , Antigènes de protozoaire/immunologie , /biosynthèse , /biosynthèse , Vaccins antileishmaniose/immunologie , Leishmaniose cutanée/immunologie , Antigènes de protozoaire , /immunologie , /immunologie , Leishmania brasiliensis/immunologie , Leishmania infantum/immunologie , Leishmania mexicana/immunologie , Leishmaniose cutanée , Leishmaniose cutanée , Foie , Souris de lignée BALB C , Saponines , Saponines/immunologie , Rate
14.
IEEE Trans Biomed Eng ; 56(3): 896-900, 2009 Mar.
Article de Anglais | MEDLINE | ID: mdl-19389688

RÉSUMÉ

This paper presents the results of a multiscale pattern-matching-based ECG encoder, which employs simple preprocessing techniques for adapting the input signal. Experiments carried out with records from the Massachusetts Institute of Technology-Beth Israel Hospital database show that the proposed scheme is effective, outperforming some state-of-the-art schemes described in the literature.


Sujet(s)
Compression de données/méthodes , Électrocardiographie , Reconnaissance automatique des formes/méthodes , Algorithmes
15.
Vet Immunol Immunopathol ; 130(1-2): 43-52, 2009 Jul 15.
Article de Anglais | MEDLINE | ID: mdl-19211152

RÉSUMÉ

When infected with Trypanosoma cruzi, Beagle dogs develop symptoms similar to those of Chagas disease in human beings, and could be an important experimental model for a better understanding of the immunopathogenic mechanisms involved in chronic chagasic infection. This study evaluates IL-10, IFN-gamma and TNF-alpha production in the sera, culture supernatant, heart and cervical lymph nodes and their correlation with cardiomegaly, cardiac inflammation and fibrosis in Beagle dogs infected with T. cruzi. Pathological analysis showed severe splenomegaly, lymphadenopathy and myocarditis in all infected dogs during the acute phase of the disease, with cardiomegaly, inflammation and fibrosis observed in 83% of the animals infected by T. cruzi during the chronic phase. The data indicate that infected animals producing IL-10 in the heart during the chronic phase and showing high IL-10 production in the culture supernatant and serum during the acute phase had lower cardiac alterations (myocarditis, fibrosis and cardiomegaly) than those with high IFN-gamma and TNF-alpha levels. These animals produced low IL-10 levels in the culture supernatant and serum during the acute phase and did not produce IL-10 in the heart during the chronic phase of the disease. Our findings showed that Beagle dogs are a good model for studying the immunopathogenic mechanism of Chagas disease, since they reproduce the clinical and immunological findings described in chagasic patients. The data suggest that the development of the chronic cardiac form of the disease is related to a strong Th1 response during the acute phase of the disease, while the development of the indeterminate form results from a blend of Th1 and Th2 responses soon after infection, suggesting that the acute phase immune response is important for the genesis of chronic cardiac lesions.


Sujet(s)
Cardiomyopathie associée à la maladie de Chagas/médecine vétérinaire , Maladies des chiens/parasitologie , Interféron gamma/biosynthèse , Interleukine-10/biosynthèse , Trypanosoma cruzi/immunologie , Facteur de nécrose tumorale alpha/biosynthèse , Animaux , Cardiomégalie/immunologie , Cardiomégalie/parasitologie , Cardiomyopathie associée à la maladie de Chagas/immunologie , Cardiomyopathie associée à la maladie de Chagas/parasitologie , Cardiomyopathie associée à la maladie de Chagas/anatomopathologie , Modèles animaux de maladie humaine , Maladies des chiens/immunologie , Maladies des chiens/anatomopathologie , Chiens , Test ELISA/médecine vétérinaire , Fibrose/immunologie , Fibrose/parasitologie , Histocytochimie/médecine vétérinaire , Interféron gamma/sang , Interféron gamma/génétique , Interféron gamma/immunologie , Interleukine-10/sang , Interleukine-10/génétique , Interleukine-10/immunologie , RT-PCR/médecine vétérinaire , Splénomégalie/immunologie , Splénomégalie/parasitologie , Facteur de nécrose tumorale alpha/sang , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/immunologie
16.
IEEE Trans Biomed Eng ; 55(7): 1920-3, 2008 Jul.
Article de Anglais | MEDLINE | ID: mdl-18595812

RÉSUMÉ

In this paper, the multidimensional multiscale parser (MMP) is employed for encoding electromyographic signals. The experiments were carried out with real signals acquired in laboratory and show that the proposed scheme is effective, outperforming even wavelet-based state-of-the-art schemes present in the literature in terms of percent root mean square difference x compression ratio.


Sujet(s)
Potentiels d'action/physiologie , Algorithmes , Compression de données/méthodes , Électromyographie/méthodes , Contraction isométrique/physiologie , Reconnaissance automatique des formes/méthodes , Traitement du signal assisté par ordinateur , Humains , Reproductibilité des résultats , Sensibilité et spécificité
17.
IEEE Trans Biomed Eng ; 55(7): 1923-6, 2008 Jul.
Article de Anglais | MEDLINE | ID: mdl-18595813

RÉSUMÉ

In this brief, we present new preprocessing techniques for electrocardiogram signals, namely, dc equalization and complexity sorting, which when applied can improve current 2-D compression algorithms. The experimental results with signals from the Massachusetts Institute of Technology - Beth Israel Hospital (MIT-BIH) database outperform the ones from many state-of-the-art schemes described in the literature.


Sujet(s)
Algorithmes , Compression de données/méthodes , Électrocardiographie/méthodes , Reconnaissance automatique des formes/méthodes , Traitement du signal assisté par ordinateur , Humains , Reproductibilité des résultats , Sensibilité et spécificité
18.
Microbes Infect ; 9(9): 1070-7, 2007 Jul.
Article de Anglais | MEDLINE | ID: mdl-17644455

RÉSUMÉ

Several antigens have been tested as vaccine candidates against Leishmania infections but controversial results have been reported when different antigens are co-administered in combined vaccination protocols. Immunization with A2 or nucleoside hydrolase (NH) antigens was previously shown to induce Th1 immune responses and protection in BALB/c mice against Leishmania donovani and L. amazonensis (A2) or L. donovani and L. mexicana (NH) infections. In this work, we investigated the protective efficacy of A2 and NH DNA vaccines, in BALB/c mice, against L. amazonensis or L. chagasi challenge infection. Immunization with either A2 (A2-pCDNA3) or NH (NH-VR1012) DNA induced an elevated IFN-gamma production before infection; however, only A2 DNA immunized mice were protected against both Leishmania species and displayed a sustained IFN-gamma production and very low IL-4 and IL-10 levels, after challenge. Mice immunized with NH/A2 DNA produced higher levels of IFN-gamma in response to both specific recombinant proteins (rNH or rA2), but displayed higher IL-4 and IL-10 levels and increased edema and parasite loads after L. amazonensis infection, as compared to A2 DNA immunized animals. These data extend the characterization of the immune responses induced by NH and A2 antigens as potential candidates to compose a defined vaccine and indicate that a highly polarized type 1 immune response is required for improvement of protective levels of combined vaccines against both L. amazonensis and L. chagasi infections.


Sujet(s)
Antigènes de protozoaire/génétique , ADN des protozoaires/immunologie , Leishmania/immunologie , Vaccins antileishmaniose/immunologie , Leishmaniose/immunologie , N-Glycosyl hydrolases/génétique , Protéines de protozoaire/génétique , Vaccins à ADN/immunologie , Animaux , Antigènes de protozoaire/immunologie , ADN des protozoaires/génétique , Femelle , Interféron gamma/biosynthèse , Interféron gamma/immunologie , Interleukine-10/biosynthèse , Interleukine-10/immunologie , Interleukine-4/biosynthèse , Interleukine-4/immunologie , Leishmania/génétique , Leishmaniose/prévention et contrôle , Vaccins antileishmaniose/génétique , Vaccins antileishmaniose/pharmacologie , Souris , Souris de lignée BALB C , N-Glycosyl hydrolases/immunologie , Protéines de protozoaire/immunologie , Lymphocytes auxiliaires Th1/immunologie , Vaccins à ADN/génétique , Vaccins à ADN/pharmacologie
19.
Parasitol Res ; 98(1): 67-74, 2005 Dec.
Article de Anglais | MEDLINE | ID: mdl-16261353

RÉSUMÉ

Acute visceral leishmaniasis is a progressive disease caused by Leishmania chagasi in South America. The acquisition of immunity following infection suggests that vaccination is a feasible approach to protect against this disease. Since Leishmania homologue of receptors for activated C kinase (LACK) antigen is of particular interest as a vaccine candidate because of the prominent role it plays in the pathogenesis of experimental Leishmania major infection, we evaluated the potential of a p36(LACK) DNA vaccine in protecting BALB/c mice challenged with L. chagasi. In this study, mice received intramuscular (i.m.) or subcutaneous (s.c.) doses of LACK DNA vaccine. We evaluated the production of vaccine-induced cytokines and whether this immunization was able to reduce parasite load in liver and spleen. We detected a significant production of interferon gamma by splenocytes from i.m. vaccinated mice in response to L. chagasi antigen and to rLACK protein. However, we did not observe a reduction in parasite load neither in liver nor in the spleen of vaccinated animals. The lack of protection observed may be explained by a significant production of IL-10 induced by the vaccine.


Sujet(s)
Antigènes de protozoaire/immunologie , Interféron gamma/biosynthèse , Leishmaniose viscérale/immunologie , Leishmaniose viscérale/prévention et contrôle , Protéines de protozoaire/immunologie , Vaccins antiprotozoaires/immunologie , Vaccins à ADN/immunologie , Animaux , Antigènes de protozoaire/génétique , Modèles animaux de maladie humaine , Femelle , Injections musculaires , Injections sous-cutanées , Interféron gamma/immunologie , Interleukine-10/biosynthèse , Interleukine-4/biosynthèse , Leishmania infantum/immunologie , Foie/parasitologie , Lymphocytes/immunologie , Souris , Souris de lignée BALB C , Protéines de protozoaire/génétique , Vaccins antiprotozoaires/administration et posologie , Rate/parasitologie , Vaccins à ADN/administration et posologie
20.
Arch Gynecol Obstet ; 273(3): 152-6, 2005 Dec.
Article de Anglais | MEDLINE | ID: mdl-16021494

RÉSUMÉ

The frequency of infectious agents for vaginitis has shown varying results. Bacterial vaginosis and candidiasis are infections related to vaginal pH alteration. Vaginal pH is related to endocervical pH in pre- and post-menopaused women, and vaginal pH in hysterectomized women is more acidic than in non-hysterectomized women. The aim of this paper is to verify differences in Papanicolaou smear diagnoses of infectious agents in hysterectomized women. A retrospective study was conducted at Faculdade de Medicina do Triângulo Mineiro (public tertiary referral centre). A total of 1,579 Papanicolaou reports for each group (hysterectomized and non-hysterectomized) was analysed. Clue cells, Candida sp., Trichomonas vaginalis, cytolysis, coccobacilli and lactobacilli were diagnosed by cytological criteria (Papanicolaou's method), statistical methods: the chi2 test and linear regression (significance level < 0.05). Clue cells decrease with the age in both the groups and are more frequent in non-hysterectomized women with > 59 years. There is an increased frequency of Coccobacilli and a decrease of lactobacillus as the age of women increases. The frequency of T. vaginalis is not influenced by hysterectomy but there is a decreased frequency between 40 years and 49 years old. Cytolysis was more frequent in women below 40 years old and between 50 years and 59 years old in both groups (P < 0.009). Candida sp. is a less common finding between 40 years and 49 years old in both groups and more frequent in hysterectomized women with > 60 years old (P = 0.002). Our results showed that the presence of infectious agents for vaginitis in Papanicolaou findings is associated with age. The frequency of finding of Candida sp. in women above 60 years old may be influenced by hysterectomy.


Sujet(s)
Hystérectomie , Vaginite/épidémiologie , Vaginite/microbiologie , Adulte , Facteurs âges , Sujet âgé , Animaux , Brésil/épidémiologie , Candida albicans/isolement et purification , Femelle , Gardnerella vaginalis/isolement et purification , Humains , Dossiers médicaux , Adulte d'âge moyen , Test de Papanicolaou , Prévalence , Études rétrospectives , Trichomonas vaginalis/isolement et purification , Frottis vaginaux , Vaginite/étiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE